Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs6903608
rs6903608
G 0.800 GeneticVariation GWASDB Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013

dbSNP: rs7745098
rs7745098
G 0.800 GeneticVariation GWASDB A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis. 24149102

2013

dbSNP: rs7745098
rs7745098
G 0.800 GeneticVariation GWASCAT A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis. 24149102

2013

dbSNP: rs2248462
rs2248462
0.800 GeneticVariation GWASCAT Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212

2012

dbSNP: rs2248462
rs2248462
0.800 GeneticVariation GWASDB Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212

2012

dbSNP: rs2395185
rs2395185
0.800 GeneticVariation GWASDB Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212

2012

dbSNP: rs2395185
rs2395185
0.800 GeneticVariation GWASCAT Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212

2012

dbSNP: rs6903608
rs6903608
0.800 GeneticVariation GWASDB Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212

2012

dbSNP: rs1432295
rs1432295
G 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs1432295
rs1432295
G 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs2019960
rs2019960
G 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs2019960
rs2019960
G 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs2608053
rs2608053
G 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs2608053
rs2608053
G 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs501764
rs501764
C 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs501764
rs501764
C 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs6903608
rs6903608
G 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs6903608
rs6903608
G 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs649775
rs649775
0.710 GeneticVariation BEFREE We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>). 30194254

2018

dbSNP: rs649775
rs649775
A 0.710 GeneticVariation GWASCAT We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>). 30194254

2018

dbSNP: rs1002658
rs1002658
T 0.700 GeneticVariation GWASCAT We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>). 30194254

2018

dbSNP: rs2425752
rs2425752
T 0.700 GeneticVariation GWASCAT We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>). 30194254

2018

dbSNP: rs2476601
rs2476601
A 0.700 GeneticVariation GWASCAT Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma. 30194254

2018

dbSNP: rs6565176
rs6565176
T 0.700 GeneticVariation GWASCAT We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>). 30194254

2018

dbSNP: rs7111520
rs7111520
A 0.700 GeneticVariation GWASCAT We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>). 30194254

2018